The Impact of Physical Training Under Normobaric Hypoxia on Oxidative Stress Level, Inflammatory State, Intestinal Damage, and Mitochondrial Metabolism in Young Males
The Influence of Physical Training in Normobaric Hypoxia on Prooxidant-Antioxidant Imbalance, Inflammatory Marker Levels, Intestinal Damage Degree, and Mitochondrial Energy Release Rate in Young Non-trained Males
- Cognitive assessment of the influence of a 4-week proprietary training program under normobaric hypoxia conditions on the levels of inflammatory markers, disturbances in prooxidant-antioxidant balance, degree of intestinal damage, and mitochondrial energy production rate in young sedentary males.
- Applied objective: Development of practical training guidelines utilizing training in normobaric hypoxia conditions to enhance mechanisms related to oxygen transport, adaptive changes within the immune system, body's antioxidant capacity, gut permeability, substrate utilization efficiency, and mitochondrial function for coaches and athletes.
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: Anna Radoń, MSc
- Phone Number: +45126831142
- Email: anna.radon@awf.krakow.pl
Study Contact Backup
- Name: Anna Kałuża, MSc
- Email: anna.kaluza@doctoral.awf.krakow.pl
Study Locations
-
-
-
Krakow, Poland, 31-571
- Recruiting
- University School of Physical Education in Cracow
-
Contact:
- Anna Radon, Msc
- Phone Number: 48 12 6831142
- Email: anna.radon@awf.krakow.pl
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- no known metabolic diseases, no contraindications to physical exercise and no history of high altitude sickness stated in interview. A medical examination (including ECG, blood and urine tests) is required.
Exclusion Criteria:
- changes in diet during the experiment, smoking and abuse of alcohol and/or other stimulants.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
No Intervention: Control group
The control group will not undergo the training program.
|
|
|
Experimental: LHTL (live high - train low)
Training performed under normoxic conditions (223m), stay and sleep in normobaric hypoxic conditions (3000m) and thermoneutral conditions (21°C) and constant humidity (40%).
|
Participants will engage in interval training and will reside and sleep at different altitudes for a period of 4 weeks.
Aerobic and anaerobic capacity tests and an eccentric exercise test will be performed before and after the training intervention.
Before and after the training program, somatic measurements will also be taken.
Before and after the first and last workout, blood will be drawn for biochemical analysis.
|
|
Experimental: LLTH (live low - train high)
Training performed under normobaric hypoxia conditions (3000m), stay and sleep in normoxic conditions (223m) and thermoneutral conditions (21°C) and constant humidity (40%). will stay and sleep in normoxic (223m), and train in normobaric hypoxia (3000m) |
Participants will engage in interval training and will reside and sleep at different altitudes for a period of 4 weeks.
Aerobic and anaerobic capacity tests and an eccentric exercise test will be performed before and after the training intervention.
Before and after the training program, somatic measurements will also be taken.
Before and after the first and last workout, blood will be drawn for biochemical analysis.
|
|
Experimental: LLTL (live low - train low)
Training performed and stay and sleep in normoxic conditions (223m) and thermoneutral conditions (21°C) and constant humidity (40%).
|
Participants will engage in interval training and will reside and sleep at different altitudes for a period of 4 weeks.
Aerobic and anaerobic capacity tests and an eccentric exercise test will be performed before and after the training intervention.
Before and after the training program, somatic measurements will also be taken.
Before and after the first and last workout, blood will be drawn for biochemical analysis.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Measurement of aerobic capacity (endurance)
Time Frame: 7 days before training and 7-10 days after the training. Training will last 4 weeks.
|
Measurement of maximal oxygen uptake and determination of ventilatory thresholds (ergospirometry)
|
7 days before training and 7-10 days after the training. Training will last 4 weeks.
|
|
Measurement of anaerobic capacity
Time Frame: 7 days before training and 7-10 days after the training. Training will last 4 weeks
|
Measurement of maximal anaerobic power (Wingate Anaerobic Test)
|
7 days before training and 7-10 days after the training. Training will last 4 weeks
|
|
Blood analysis
Time Frame: 7 days before training and 7- 10 days after the training. The training will last 4 weeks and will consist of 12 workouts.
|
Indicators of prooxidant-antioxidant imbalance, markers of inflammatory status, markers of muscle damage, markers of intestinal damage, HIF (hypoxia-inducible factor), EPO (erythropoietin), markers of mitochondrial metabolism, morphology (including reticulocytes).
|
7 days before training and 7- 10 days after the training. The training will last 4 weeks and will consist of 12 workouts.
|
|
Somatic indices
Time Frame: 7 days before training and 7-10 days after the training. Training will last 4 weeks.
|
Body composition analysis ( body height [m], body mass [kg], Quetelet II Index [kg/m^2], lean body mass [kg], fat mass [kg], fat percentage [%] and total water content [kg]
|
7 days before training and 7-10 days after the training. Training will last 4 weeks.
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- SKN/SP/570048/2023
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.